Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica M Salmon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|February 20, 2021
Author Correction: Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cellsCedric S Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2020
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive ChemotherapyChong Chyn Chua, Andrew W Roberts, John Reynolds, et al.
Science Translational Medicine|May 20, 2016
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemiaGabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Cancer Cell|September 14, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cancer Discovery|March 21, 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AMLJessica M Salmon, Izabela Todorovski, Kym L Stanley, et al.
Cell Stem Cell|August 3, 2019
Interconversion between Tumorigenic and Differentiated States in Acute Myeloid LeukemiaMark D McKenzie, Margherita Ghisi, Ethan P Oxley, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|February 20, 2021
Author Correction: Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cellsCedric S Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2020
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive ChemotherapyChong Chyn Chua, Andrew W Roberts, John Reynolds, et al.
Science Translational Medicine|May 20, 2016
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemiaGabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Cancer Cell|September 14, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cancer Discovery|March 21, 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AMLJessica M Salmon, Izabela Todorovski, Kym L Stanley, et al.
Cell Stem Cell|August 3, 2019
Interconversion between Tumorigenic and Differentiated States in Acute Myeloid LeukemiaMark D McKenzie, Margherita Ghisi, Ethan P Oxley, et al.
Pageof 2